IFx-Hu2.0
MCC 2023-01
Phase 3 small_molecule active
Quick answer
IFx-Hu2.0 for Advanced Or Metastatic Merkel Cell Carcinoma is a Phase 3 program (small_molecule) at TuHURA Biosciences, Inc./NV with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TuHURA Biosciences, Inc./NV
- Indication
- Advanced Or Metastatic Merkel Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active